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Abstract
Malaria driven pathophysiology inimically conjoined to systemic inflam-
mation response cascade in a vicious feed-forward cycle destined to a terrible 
debilitation or demise of the host. The Plasmodium parasite initiates physiologi-
cal changes when it is transmitted into the human host by intermediate host and 
vector. Sporozoites injection elicits immunological and inflammatory response 
suppression facilitating movement into the blood stream undetected, destined 
to hepatocyte. Subsequently, hepatocyte invasion culminates in intracellular 
growth and conversion of the parasites rapturing hepatocytes releasing merozo-
ites into the extrahepatic circulation. Inflammatory and immunological response 
initiation results in overt malarial disease symptoms. Initially, inflammatory 
response alleviates and curtails infection. Activation of leukocytes, lympho-
cytes, monocytes, and phagocytes secretes inflammatory mediators, chemo-
kines, cytokines cytoadhering molecules which accelerate infection patency. 
Hormonal processes influence disease tolerance without necessarily interfering 
with parasitemia. Current treatment is anti-parasitic. Phytotherapeutic interven-
tion in malaria is anti-parasitic and anti-disease effects that terminate the vicious 
cycle and alleviating disease. The phytochemicals, in malarial experimental and 
clinical work, include asiatic acid, maslinic acid, oleanolic acid, and inflam-
matory and immunological aberrations evolving in malaria and the effects of 
phytochemical therapeutics in the alleviation of the disease to enable leverage 
of future treatment regimens through harnessing existing plants materials is 
explored.
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Malaria and inflammation seem to be intricately connected with the 
Plasmodium parasite having evolved mechanisms to evade its initiation before 
the parasite has set a strong and indelible foot print in either the intermediate 
(mosquito) or definitive (animal or human) hosts. Pathogen-driven tissue dam-
age complements inflammatory response building a debilitating state against host 
fitness and survival [1, 2].
The disease is premised upon an immunological disease and a systematic inflam-
matory syndrome with a strong cachectic constituent driven by an endogenous 
cytokine milieu in the form of the pyrogens tumor necrosis factor alfa (TNF-α) and 
interleukin-1 (IL-1) [3, 4]. Eliciting and chaperoning this immunological-inflam-
matory response to malarial infection are the glycolipid glycosylphosphatidylino-
sitol (GPI) moieties which are covalently connected to the antigens on the exterior 
topological aspect of malaria parasites or free in circulation. Whether linked to the 
parasite related proteins or free, GPI induce elevated levels of TNF-α and IL-1 from 
macrophages resulting in pyrexia, cachexia and, through their insulin memetic 
effect, regulate glucose homeostasis in adipocytes with profound hypoglycemia 
initiation [5]. In attends to these GPI-induced cytokine inflammatory effects and 
other malaria parasites by products like hemozoin, are the common malarial syn-
dromes of severe malaria anemia (SMA), hypertriacylglycerolemia, hypotension, 
pulmonary vasculature hyperneutrophilia and acute respiratory distress syndrome 
(ARDS), diffuse intravascular coagulation, upregulated expression of endothelial 
cell and vascular cell intercell adhesion molecule 1 (ICAM1 and VCAM 1) [6, 7]. 
Mature parasites tend to recognize these molecules leading to their sequestration in 
cerebral malaria (CM) [8].
In a bid to neutralize the disease sequelae and induce disease tolerance (anti-dis-
ease effects), albeit without reduction in parasitemia (anti-infection effects) are the 
adrenal glands hormones which mediate immunological-inflammatory responses 
but do not affect the pathogen load [9]. Other hormones play a critical role in the 
amelioration of malarial inflammation.
Investigations and diagnosis of malarial-related inflammation and immuno-
logical aberrations have been vast owing to the importance of the tropical and 
subtropical disease. However, a lull in research has been experienced in the past 
making malaria one of the forgotten diseases. Interest has resurged in both disease 
investigations and management.
Malarial inflammatory response yields itself into the pathophysiology of 
malaria intimating that management needs to be directed at both the parasite and 
the disease, antiparasitic and anti-disease, respectively. The animal host develops 
disease tolerance through immunological and inflammatory response to a limited 
extent depending on the rate and duration of exposure to potent infection transmit-
ting mosquito bites. Management of the disease with antiparasitic regimens alone 
or anti-disease management alone does not result in a radical cure but provides 
opportunity for future parasite recrudesces and drug resistance.
Phytotherapeutics and their derivatives have been administered in both 
experimental research and clinical practices with astonishing results. The drug 
artemisinin (extract from Chinese artemisinin annua herb) and its derivatives 
provide current mainstay of malaria treatment such that any meaningful parasite 
resistance to the drug will thrust the world into an era without effective malaria 
treatment. Anti-inflammatory activities have been reported for the drug. However, 
the proposed mode of action of the drug has been through a pro-oxidant capacity 
driven the endoperoxidase activity of the molecule which eventually is a compelling 
proinflammatory oriented outcome that rapidly kills the parasites. This process 
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leaves behind an oxidative environment with possible fatal hemolytic episodes 
occurring days after successful treatment of the disease in what has been termed 
post artemisinin administration hemolytic diseases. Alternative and safer treatment 
regimens are urgently required.
Experimental phytotherapeutics administration in murine malaria, the likes 
of triterpenes Asiatic acid (AA), Maslinic acid (MA) [10] and Oleanolic acid 
(OA) have shown potential antiparasitic and anti-disease facultative propensities. 
Salvaging of inflammation-driven glucose homeostasis, acute renal injury (ARI), 
hyperlipidemias, hyperparasitemia, hyperinsulinemia, cerebral malaria, weight loss 
and reduced feeding disease patterns have been reported. Triterpenes have pleiotro-
pic characteristics with both antioxidant and pro-oxidant properties dependent on 
the environmental homeostasis. A plethora of challenge bedevil malaria manage-
ment. There is antimalaria multidrug resistance, high cost of antimalarials, poverty 
amongst those most affected by malaria, lack of 100% effectiveness of current anti-
malaria drugs, no efficacious vaccine against malaria in place yet and adverse drug 
related post treatment side effects are common constraints in malaria management. 
Therefore, it is imperative that alternative drugs, as suggested here, be explored or 
leads compounds with antimalarial disease alleviation properties be reported for 
either more work to be done or be implemented in human trials.
2. Malarial cycle and potential interventional areas
2.1 Parasitemia drives malarial inflammatory response
Malaria is a highly inflammatory condition characterized by acute periods of fever, 
headache and nausea which correspond to the release of merozoites into the blood 
stream as the erythrocytes rapture. Excessive erythrocyte rupture leads to anemia and 
high parasitemia. Molecules from the parasite and ruptured RBCs trigger host inflam-
matory responses [11]. The erythrocyte stage is characterized by up-regulation of 
inflammation-driving cytokines such as IL-1b, IL-6, IFN-g, TNF-a and IL-12 [12, 13], 
which may lead to excessive inflammation if not curtailed [14]. Some parasite molecules 
that have been associated with host inflammatory responses include glycosylphosphati-
dylinositol (GPI) anchors, hemozoin, uric acid and parasite DNA [5, 15–17].
In vitro studies showed induction of nitric oxide, TNF and IL-1β by parasite 
GPI-anchors while synthetic and purified [19] Plasmodium GPI had immunogenic 
properties in vivo. Plasmodium species produce hemozoin as they detoxify heme in 
pRBCs. The hemozoin induce IL-1β production by immune cells such as monocytes 
and macrophages once released into circulation during pRBCs lysis [20]. Hemozoin 
has been demonstrated to activate the inflammasome protein complex [21, 22] and 
injection of parasite-derived hemozoin in disease-free mice induce transcription of 
inflammatory genes [23]. Parasite DNA has also been shown to induce cytokine and 
chemokine responses by human plasmacytoid dendritic cells by the activating the 
TLR9-MyD88 signaling pathway [24].
Parasite DNA is also detected by several cytosolic DNA sensors in the cytoplasma 
upon release of phagolysosomal contents [25]. Uric acid derived from the parasite and 
from the rupture of infected pRBCs has also been reported to induce strong inflam-
matory responses in patients [11]. In vitro studies show that uric acid derived from 
the parasite promotes secretion of pro-inflammatory cytokines that include TNF, 
IL-1β and IL-6 by [26]. The uric acid levels are specifically elevated in periods cor-
relating with parasitemia [27, 28]. Overall, the role of parasitemia and components of 
the parasite in pathological inflammation response is an on-going concern poised for 
novel target development for diagnosis and anti-inflammatory antimalarials.
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2.2 Inflammatory cytokines in severe malaria
P. falciparum infection is associated with the release of proinflammatory cytokines 
which are crucial in mediating the control of parasite growth and sickness behaviors in 
the host e.g., lethargy, fever, anorexia, pain [7, 29, 30]. The excessive production of these 
mediators is implicated in host-harming effects associated with infection. However, the 
inflammatory response is a highly regulated response regulated, in part, by the produc-
tion of cytokines. Apparently, malaria disease outcome depends on the delicate balance 
between proinflammatory and anti-inflammatory cytokines. Development of severe 
forms of the disease and death depends on the rapture of this balance [31–33].
During malarial infection, the recognition of different pathogen related mol-
ecules expressed by the parasite or released by the host stimulate the immune 
system and cytokine production. A glycolipid toxin of P. falciparum, glycosylphos-
phatidylinositol (GPI), is a potent pathogen associated molecular pattern (PAMP) 
expressed on the parasite whose interaction with the host immune system induces 
the expression of genes encoding pro- and anti-inflammatory cytokines including 
TNF-α, IL-1, IL-6, IL-12, IL4, IL10 and the enzyme inducible nitric oxide synthase 
(iNOS) [5, 34]. GPI interacts with toll like receptor (TLR)1/TLR2 and TLR2/
TLR6 dimers, and possibly C-type lectins on dendritic cells and macrophages to 
produce proinflammatory cytokines. Hemozoin, a PAMP and detoxification crystal 
from hemoglobin binds to TLR9 and mediates the production of proinflammatory 
cytokines in dendritic cells and macrophages [35, 36].
Pure hemozoin is not a ligand for TLRs but acts a carrier molecule for malarial DNA 
which has the immunostimulatory effects [37–39]. The P. falciparum genome contains 
CpG motifs which act through the MYD-88-NFkβ to induce cytokine production. P. 
falciparum DNA also contains the highest AT content and the AT motifs induce the 
production of interferons [16]. Other proteins, sugars, RNA motifs and other phos-
phorylated non-peptidic antigens are known to be PAMPs with cytokine induction 
potential [7, 36, 40]. In addition to parasite expressed proinflammatory molecules, 
several host-derived molecules, commonly known as damage associated molecular 
patterns (DAMPs), are also involved in evoking the inflammatory response and 
cytokine release in severe malaria. These include nucleic acids and urate crystals, heme 
and microvesicles derived from platelets, endothelial cells and leukocytes [11, 41–43].
2.2.1 Tumor necrosis factor-α (TNF-α)
TNF-α is involved in the pathogenesis of malaria associated with disease severity 
and death. TNF-α is dramatically increased with up to two- and ten-fold concen-
trations in cerebral malaria (CM) and in fatal cases, respectively [44, 45]. TNF-α 
concentrations are associated with parasite clearance and blocking TNF-α function 
increases the risk of hyperparasitemia [46]. The administration of recombinant 
TNF also induce clinical manifestations characteristic of malarial pathology includ-
ing fever, anemia and hypotension [47, 48].
The susceptibility of an individual to cerebral malaria is linked to the presence 
of a genetic variant of the gene that encodes the TNF promoter [49]. TNF-α exacer-
bates sequestration in cerebral blood vessels in the brain by increasing the expres-
sion adhesion molecules e.g., ICAM-1 in the endothelial cells [50]. However, there is 
contrary knowledge on the role of TNF-α in the pathogenesis of severe and cerebral 
malaria [51–53]. Blocking TNF-α using anti-TNF antibodies does not seem to reduce 
mortality in CM [54] although it successfully stops fever suggesting that the full 
biological effects of TNF may be a concerted effort with a complex network of other 
cytokines. TNF-α is produced quite early during infection and has a short half-
life, hence the timing of TNF-α neutralization in inflammation has to be carefully 
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considered. Blocking TNF-α when patients are already severely ill may be too late as 
an intervention to show anti-inflammatory efficacy of this process.
2.2.2 Lymphotoxin-α
Other cytokines demonstrate similar proinflammatory activity as TNF-α. 
Lymphotoxin-α (previously known as TNF-β) is a proinflammatory cytokine 
produced by lymphocytes which shares the same receptors with TNF and exhib-
its similar biological effects as TNF-α. Like TNF-α, lymphotoxin acts in synergy 
with IL-1 to increase the production of IL-6 and induce hypoglycemia; both are 
which are prominent clinical features in severe malaria [55]. Lymphotoxin also 
mediates the cell-mediated killing of P. falciparum parasites in infected erythro-
cytes [56].
2.2.3 Interferon γ
Another prominent proinflammatory cytokine in malarial pathology is IFNγ. 
IFNγ is produced by both CD4+ and CD8+ T lymphocytes during malarial infec-
tion. IFNγ activates macrophages and monocytes to produce other proinflamma-
tory molecules including TNF, IL-1, IL-6, TGF-β and NO intermediates which help 
to kill the malarial parasite. As a result of its ability to induce TNF production, IFNγ 
has been implicated in the pathogenesis of cerebral malaria and blockage of IFNγ 
action was reported to prevent against cerebral malaria in murine models [57]. 
Additionally, IFNγ knockout mice showed resistance against cerebral malaria but 
were still susceptible to severe malaria and death. The release of IFNγ is controlled 
by IL-12 [58] and its relevance in severe disease may depend on the levels, timing 
and balance with other cytokines.
2.2.4 Interlukin-1
Interleukin-1 is a proinflammatory cytokine produced by macrophages, 
natural killer cells, B cells, dendritic cells and other immune cells. Serum concen-
trations of IL-1 correlate strongly with severity of disease with higher IL-1 levels 
observed in patients with CM and greater than in those in severe malarial anemia 
[59]. IL-1 has synergistic interactions with TNF-α and increases the expression 
of the adhesion molecule ICAM-1 in cerebral vasculature thus exacerbating 
sequestration.
2.2.5 Interleukin-6
IL-6 is proinflammatory cytokine released by monocytes/macrophages and Th2 
cells. Serum concentrations of IL-6 vary with severity of disease with higher levels 
in CM than in severe and in uncomplicated cases [59]. IL-6 mediates TNF-α func-
tions in severe malaria.
2.2.6 Interleukin-10
While proinflammatory cytokines play a critical role in the host immune defense 
against the malaria parasite, poorly regulated release of these chemical molecules 
results in the immunopathological response characteristic of severe malaria. 
Proinflammatory cytokines release is closely regulated by anti-inflammatory 
cytokines. IL-10 inhibits the release of Th1 type of cytokines but not Th2 showing 
its negative correlation with TNF-α, IL-1β and IL-8 [60].
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Progression of malaria from uncomplicated to more severe forms is the func-
tional balance of anti-inflammatory to proinflammatory cytokines than it is about 
individual cytokine levels. This explains why severe malaria does not occur in all 
cases where proinflammatory cytokine concentrations are very high. A downregu-
lation of IL-10 coupled to the upregulation of TNF is usually associated with severe 
and CM. Thus, it is important to consider the ratio of IL-10 to TNF-α [61, 62].
2.2.7 Transforming growth factor-β (TGF-β)
TGF-β is an anti-inflammatory cytokine that immune-regulates malaria. A 
TGF-β neutralizing antibody in malaria infected mice is associated with dramatic 
increases in TNF-α and IFN-γ concentrations. TGF-β also upregulates IL-10 pro-
duction while downregulating the expression of adhesion molecules, decreasing 
sequestration of pRBCs in severe malaria. Interestingly, at low concentrations 
TGF-β exhibits proinflammatory effects but has anti-inflammatory effects at high 
concentrations [63]. In malaria, the multifunctionality of TGF-β serves two impor-
tant functions; (1) enhancing Th1 mediated parasite control during early infection, 
and (2) regulating the inflammatory response in later phases to prevent immunopa-
thology [63].
3.  Inflammation-induced mitochondrial dysfunction and cellular energy 
depletion in malaria
Parasitized red blood cells (pRBC’s) agglutination to the endothelium causing 
blood vessels occlusion solely has been the ascribe process by which tissue hypoxia 
in malaria occurred. However, other mechanisms have since been elucidated as 
contributing to this phenomenon [64, 65]. Sepsis shares the same systemic pathol-
ogy and disease presentation of tissue underlying tissue hypoxia with malaria but 
does not experience RBC’s sequestration. Which may indicate other causes of the 
complication. In sepsis tissue oxygen tension is usually normal or elevated in the 
rat, patients or pigs [66]. This bring to the fore the aspect that poor oxygen utiliza-
tion, compared to supply, as the major cause of malaria-related hypoxia.
Excessive reactive oxygen species (ROS), nitric oxide (NO) and peroxynitrite 
(ONOO−), as seen in malaria, tend to cause mitochondria dysfunction. Pro-
inflammatory cytokines induce excessive inducible nitric oxide synthase (iNOS) 
expression by monocytes and macrophages tend to increase NO and subsequently 
oxidative stress (OS). Increase OS reversibly inhibits cytochrome oxidase and 
aconitase [67, 68] with concomitant energy reduction with respiration fatigue and 
tissue hypoxia. Together or as separate phenomena, reduction in energy utilization 
potential and oxygen transportation, play a crucial role in the generation of hypoxic 
conditions of malaria in an escalating feed-forward mechanism.
Another mechanism for hypoxia in malaria involves the nuclear enzyme poly 
(ADP-ribose) polymerase (PARP). PARP catalyzes transfer of ADP-ribose units 
from β-nicotinamide adenine dinucleotide (NAD+) to produce linear and branched 
polymers from a number of different proteins. The normal and malarial inflamma-
tion-driven DNA damages repair mechanism is the same mechanism that activates 
PARP. Activation of PARP invariably consumes NAD+ and conversely leads to the 
depletion of ATP. Intriguingly, breaks of DNA strands may be initiated by oxygen free 
radicals or their NO reaction products ONOO− as OS. ROS and DNA strands breaks 
reigns supreme in malaria inflammation with consequential depletion of NAD+ and 
decreased ATP generation without the critical NAD+ [69]. Aerobic respiration is thus 
invariably compromised with the possibility of bioenergetics failure through increased 
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glycolysis which generates insufficient energy and hyperlactemia. In malarial inflam-
mation, there is increased generation of ONOO− through induction of iNOS and 
subsequently NO, which activates over expression of PARP through increased DNA 
damage. Concomitantly, a vicious cycle of mitochondrial dysfunction leading to ATP 
rundown predisposes to polymyopathy, hypoglycemia, hyperlactemia. The facets have 
been hitherto mostly attributed to poor oxygen delivery in malaria [70].
The solution to energy regeneration may be through prevention of PARP-induced 
energy rundown and may comprise of (i) increasing supply of NAD+, (ii) PARP 
activation-inhibition, (iii) quenching the inflammatory drivers of PARP activation, 
i.e., NO and ONOO−, or stopping DNA damages by other means [71]. However, 
supplementation with NAD+ in sepsis or malaria is somewhat impractical; inhibition of 
PARP may have deadly effects if it was possible; elimination of DNA damage is impos-
sible. Quenching the pro-oxidant drivers of activation of PARP through DNA damage 
seem the most plausible method to protect against both the inflammasome and energy 
rundown. Indeed, certain agents have been reported to protect against free radical 
oxidation inhibiting PARP activation salvaging brain ischemia, splanchnic ischemia and 
reperfusion [72–74], lipopolysaccharide-induced toxicity, local inflammation and brain 
pathology in mice, multi-organ failure in rats and sepsis of the pigs [75, 76].
The other fascinating feature in PARP is that transcription factor NF-kβ is 
intricately connected the activation of the nuclear enzyme. Also, NFkβ is involved 
in DNA repair, immunological response and apoptosis placing it pivotally in the 
expression of genes essential to systemic inflammatory disease mainly, TNF-α and 
interleukin-1 (IL-1), IL-1β, IL-6, IAM-1, E-selectin and iNOS [77–82].
Essentially, PARP activation through ONOO− as a result of inflammation, con-
sumes NAD+ causing poor energy utilization and energy depletion [69]. Subsequent 
to inflammation-driven PARP activation through ONOO−, tissue hypoxia (from 
increased NAD+ consumption) sets in causing more inflammation-induced tissue 
damage, increased inflammatory cytokines synthesis and more ONOO− production 
[69]. Coma and death are inevitable from the vicious cycle of severe inflammation 
breeding more of itself leading to multi-organ failure, ultimately [70]. As a result, 
anti-inflammatory agents like Asiatic acid may have indispensable roles, through 
inhibition of NF-kβ, in the assuagement of malarial disease which essentially is 
underscored by inflammatory processes.
4. Malarial oxidative stress-driven inflammatory response
Reactive oxygen species have destructive effects through their ability to increase 
oxidative stress. Malaria disease is able to orchestrate multi-organ injury and 
disintegration through the ROS’s disparaging properties. Oxidative stress (OS) 
has a fundamental role in pRBC’s influence to disease manifestation comprising 
of pRBC’s vascular sequestration, AKI, CM, SMA and ARDS [83, 84]. The defense 
mechanism of ROS and reactive nitric oxide species (RNOS) against disease and 
their signal transduction capacities make them have a both beneficial and patho-
logical role in malaria necessitating regulation.
Plasmodium parasites have contracted capacities to mobilize amino acids and 
depend on hemoglobin (Hb) breakdown, a process with a high potential to gener-
ate ROS. Hb breakdown yields heme and globin (protein), with the former being a 
highly toxic compound which generates high OS activity at very low concentrations. 
Hb-free heme contains ferri/ferroprotoporphyrin IX (FP-IX) a very reactive iron-
containing compound which generates an OS environment. Detoxification of heme 
by the parasite to hemozoin (β-hematin) is necessary and critical [85, 86]. Failure 
to convert heme to its biocrystallization or biomineralization form will oxidize the 
Parasitology Research
8
parasite food vacuole membranes destroying it in the process. Chloroquine and 
other 4-aminoquinolines use this principle to dislocate parasite proliferation by 
inhibiting heme biocrystallization in pRBC’s and increasing OS [85–89].
There is a high overall oxidative load that the host cell immune response to 
parasitemia likewise yields to the pRBC. Nevertheless, the parasite has developed 
mechanisms for amplified antioxidant capacity, which may only be overcome by an 
extremely oxidative agent [83, 90–93]. Agents that inhibit hemozoin creation from 
heme have since been rendered impotent through multidrug resistance (MDR) 
processes that extrude the drug from the food vacuole protecting the parasite from 
possible oxidative stress.
On the other hand, ROS may be deliberately generated and targeted at certain 
parasite enzymes and membranes, as what is witnessed in the use of endoperoxi-
dase antimalarials, with higher chances of faster parasitemia clearance although 
with higher tissue inflammation induction as well [94].
Antioxidants may have an anti-inflammatory effect in malaria where inflamma-
tion is generated from OS. However, OS is beneficial in malarial parasite eradication. 
Pleiotropic characteristics of triterpenes, antioxidant and pro-oxidant, seem to be 
very ideal properties for combating malaria. Indeed, it has since emerged that certain 
phytotherapeutics do eradicate parasitemia while ameliorating the pathophysiol-
ogy of malaria like inflammation [95] and severe malaria anemia [96]. Buttressing 
the antioxidant capacity of triterpene phytotherapeutics are findings that oral 
administration of Asiatic acid (20 mg/kg) in streptozotocin-induced diabetic rats 
up-regulated both enzymatic and non-enzymatic antioxidants with subsequent 
lipid peroxidation abating [97] and salvaged diabetic rats [98] where increased OS is 
common. Of note is that superoxide dismutase (SOD), catalase (CAT), glutathione 
peroxidase (GPx) and glutathione-S-transferase (GST), ascorbic acid and reduced 
glutathione (GSH) tend to be elevated in the phytochemical is administered animal 
experimental DM [97–99]. Moreover, severe malaria is accompanied by marked lipid 
peroxidation, prevention of which by triterpenes testifies their efficacy against OS 
driven inflammation in malaria and acute renal injury [100].
5.  Hormonal anti-inflammatory processes in malaria mediate glucose 
homeostasis
Complications of malaria including CM, SMA, placental malaria, hypoglycemia, 
ARDS are not efficaciously resolved despite the effective parasitemia inhibition by 
current antimalarial agents [9]. Parasite infection and/or exaggerated immune reac-
tion [101] contribute to malarial complications necessitating treatment emphasis on 
more than just pathogen clearance but extending it to host defense mechanism that 
do not interfere with parasitemia load. The malarial disease tolerance or anti-disease 
process has been linked to heme oxygenase [102] and to Fe3+ sequestration protein 
ferritin [103] and some novel phytotherapeutics [96]. Glucocorticoids (GC), cortisol 
in the human and corticosterone in rats and mineral corticoids (MC) are adrenal gland 
cortex products and the adrenaline-noradrenaline combination are from the adrenal 
medulla. Adrenal cortex responds to the circadian rhythm, when the hypothalamus-
pituitary–adrenal axis is activated, in stress/trauma situations, infection or systemic 
inflammation [104] by producing hormones to influence metabolism, immunity, bone 
remodeling, cardiovascular function, reproduction and cognitive processes [105].
GC’s have anti-inflammatory properties and differential effects on numerous 
leukocytes phenotypes [106, 107]. In response to GC’s, liver, muscle, adipose tissue 
increase gluconeogenesis, protein catabolism and lipolysis, respectively, to increase 
glucose directly or indirectly [108]. Upon human malarial (P. falciparum or P. vivax) 
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infection, GC’s (cortisol) are the only hormones of the adrenal gland [109]. Malaria 
infection and pregnancy-associated corticosterone concentration increases cause the 
loss malarial immunity and recrudescence [110–112] with adrenalectomy reducing 
survival in mice infected with P. berghei K173 parasite [113]. Infection of adrenal-
ectomized mice causes lethal hypoglycemia of insulin- and TNF-α-independent 
type with increased inflammation [9]. The phenotype is characterized by exhausted 
hepatic glycogen stores, no increase in glucogenesis and is rescued by dexametha-
sone administration. This shows that GC’s are essential for malarial disease tolerance 
through modulation of inflammatory mediators. Notably, raised cytokine concentra-
tion tend to be observed in both the circulation and the brain; adrenal hormones 
differentially disturb inflammation in the brain and circulation compared to liver 
and lungs. Together with inflammation, marked hypoglycemia sufficient to cause 
functional brain failure and coma, has been observed with rapid brain death [114]. 
Hypoglycemia is a major life threat in malaria and glycemia correlates with clinical 
scores negatively regular consistence. Moreover, plasma glucose concentrations 
negatively correlate with brain concentrations of mRNA’s encoding TNF-α, IL-1β, 
IL-6, CCL2 and iNOS, signifying the possible linkage between hypoglycemia and 
expression of these pro-inflammatory markers. Plasma concentrations of chemo-
kines, cytokines and with the exception of IL-4, tend to be negatively interrelated to 
plasma glucose concentration. Notwithstanding hypoglycemia, hyperlactemia in 
acidosis, resulting from increased glycolytic flux, may complicate malarial infection.
After malaria infection, hepatic gluconeogenic transcriptional response is dimin-
ished regardless of increases in GC concentration showing the importance of adrenal 
glands in maintaining blood glucose concentration in malaria. The classical glycemia-
regulating principles of adrenal corticosteroids includes transcriptional induction of 
gluconeogenic response in the liver and increase plasma free fat acids concentrations.
In the absence of adrenal hormones, like in adrenalectomy, malaria causes com-
plete exhaustion of hepatic glycogen stores. This creates irreversible severe hypogly-
cemia that may not be rescued by glucose supplementation by oral or intraperitoneal 
(i.p.) injection route in mice. Parasitemia remains unaffected by glucose supple-
mentation in such situations. Amazingly, even the neutralization of the most potent 
pro-inflammatory cytokine, TNF-α, does not seem to salvage from lethal hypoglyce-
mia in the absence of adrenal glands. Also, adrenal hormone absence in malaria affect 
glycemia independent of insulin secretion. Overall, malaria infection is moderated 
by adrenal hormones to alleviate hypoglycemia which cannot be reversed by glucose 
administration, insulin blocking with clonidine, neutralizing of TNF-α but is rescued 
by dexamethasone, a GC analog [9]. A similar effect has been shown when triterpene 
phytotherapeutics, potent anti-inflammatory capacity, are administered in murine 
malaria [115] also showing inflammation involvement in malarial lethality.
6. Inflammation and the pathogenesis of cerebral malaria
Cerebral malaria is the most severe neurological complication of malaria. It is a 
clinical syndrome characterized by coma and other acute and or chronic neurological 
disturbances. In children, coma may develop with seizures often following weakness 
and prostration. Other neurological symptoms include encephalitis, intracranial 
hypertension, retinal changes and brainstem signs (impaired pupillary reflexes, posture 
problems and abnormal eye movements) [116, 117]. In adults, patients develop fever 
and headaches and progressive delirium and coma but seizures and retinal abnormali-
ties are less common [116, 117]. Several neurological sequelae have been associated 
with cerebral malaria and these include; spasticity (hemiplegia, quadriparesis or 
quadriplegia), hypotonia, cranial nerve palsies, ataxia, visual disturbances, aphasias, 
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neurocognitive deficits, epilepsy and some behavioral and neuropsychiatric distur-
bances. These sequelae may occur in the short-term and resolve, or may persist long 
term [117].
The pathogenesis of cerebral malaria has been be explained according to two 
theories: (1) the occlusion theory, or (2) the inflammation theory. The occlusion 
theory, supported by vast scientific evidence, suggests that brain injury and the 
resultant neurological disturbances are the result of increased sequestration of blood 
cells to the brain microvasculature which reduces perfusion and may cause ischemia 
and tissue injury. Increased sequestration of infected red blood cells, leukocytes 
and platelets is well known to occur in cerebral malaria [118–120] but the occlusion 
theory does not adequately explain how some fatal cases of cerebral malaria occur 
with little to no sequestration. Additionally, although P. vivax is not likely to seques-
ter in brain vasculature, there have been isolated cases of P. vivax infection-related 
cerebral malaria cases [121]. These gaps in our knowledge of the pathogenesis of 
cerebral malaria have led to an increased interest in other possible pathologic mecha-
nisms which may work independently or together with occlusion to cause cerebral 
malaria and related neurological disturbances. Stimulation of a local inflammatory 
response in the brain has been coined as an alternative or accompanying mechanism 
in the pathogenesis of cerebral malaria and is summarized in Figure 1.
The blood brain barrier (BBB) endothelium responds to PAMPs, DAMPs and 
peripheral cytokines and is now regarded as an integral part of the neurovascular 
unit. In response to these immunostimulatory molecules, endothelial cells produce 
proinflammatory cytokines and chemokines that mediate leukocyte recruit-
ment and thus trigger local inflammation [122, 123]. Leukocytes further release 
proinflammatory cytokines and thus set up a vicious inflammatory cycle which 
exacerbates local inflammation with the brain. As part of the BBB, the integrity 
of the endothelium is central to BBB function and brain protection. Inflammatory 
activation of the endothelium has been associated with increased BBB permeability 
through the induction of regulatory miRNAs that reorganize endothelial tight junc-
tions [124, 125]. This renders the BBB leaky and allows passage of substances into 
neural tissue, leading to neurotoxicity. Clinically the progression of cerebral malaria 
has been closely associated with changes in BBB function as evidenced by hemor-
rhages in cerebral malaria and loss of endothelial intercellular junctions in pediatric 
fatal cerebral malaria (Figure 2) [132].
Figure 1. 
Malaria Cycle and therapeutic possible cites [18].
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The production of proinflammatory cytokines in the brain could also be involved 
the development of encephalopathy. For example, TNF has been reported to regulate 
synaptic function and to cause glutamate neurotoxicity [127]; mechanisms which are 
closely linked to the development of seizures and neurocognitive deficits. IL-1 and 
TNF have also been shown to inhibit long term potentiation [128] and it is possible 
that high levels of these cytokines produced in severe malaria could be involved in 
the development of cognitive deficits associated with the disease.
7. Medicinal plants
Exposure to Plasmodium infection leads to elevation of pro-inflammatory mark-
ers such as TNF-α and interleukin-1 (IL-1) from macrophages and lymphocytes. 
Natural products have attracted interest due to their affordability to the general 
communities with low socio-economic status. Below is the description of the 
triterpenes that possess anti-inflammatory properties.
7.1 Synthetic oleanolic (SO) pentacyclic triterpenes derivatives
CDDO-EA (Figure 3) is a synthetic oleanolic derivative that has been shown to 
possess various biochemical activities which include efficacy against cerebral malaria 
(CM) [129]. The development of severe CM is associated with dysfunction of the 
Figure 2. 
Inflammatory events involved in the pathogenesis of cerebral malaria endothelial intercellular junctions in 
pediatric fatal cerebral malaria [126].
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immune system as shown by plasma levels of TNF-α and IFN-γ [59, 130]. A single 
injection dose of CCDO-EA (200 μmol/kg) lowered circulating levels of TNF-α and 
IFN-γ which improved mice survival and lowered inflammation [129]. Indeed, studies 
have indicated that the host’s response to malaria is excess production of pro-inflam-
matory molecules which are thought to be central causes of inflammation in malaria.
7.2 Ursolic acid
Ursolic acid (3-hydroxy-urs-12-ene-28-oic acid, Figure 4) is triterpene which 
is widely distributed on different medicinal plants. UA has been shown to exhibit 
a number of pharmacological activities which include, anti-microbial [132], 
anti-malarial [133] and potent anti-inflammatory properties [134]. Although 
Figure 3. 
Chemical structure of a synthetic oleanolae derivative [129].
Figure 4. 
2D chemical structure of ursolic acid [131].
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no research has been done on anti-inflammatory properties of this triterpene in 
malaria rats, several studies have evaluated anti-inflammatory properties on other 
experimental models in vivo and in vitro [134]. However, several studies have 
evaluated the anti-inflammatory properties of the compounds in in-vitro and 
in vivo. Tsai and Yin’s reports indicate that UA and oleanolic acid (OA) alleviate 
inflammation through reduction of IL-6 and TNF-α [135]. Additionally, studies 
also validate the anti-inflammatory potency of UA by reducing the production of 
IL-2 and through activation of T-helper cells [136]. Liu et al., have shown that UA 
suppressed T cell responses including NF-kB inhibition at 25 mM while Bharata 
et al. demonstrated the efficacy against a lowers dose of UA IS enough to lower 
immune cells such as T-cells, B-cell, and macrophage activation. Apart from this, 
Xu et al. have shown that anti-inflammatory effects of UA are mediated through.
7.3 Maslinic acid (MA) and oleanolic acid (OA)
Maslinic acid and oleanolic acid are two triterpenes widely abundant in olive 
trees and Syzygium spp. Among many pharmacological properties, these triter-
penes have demonstrated efficacy against malaria [133]. The triterpenoids are 
generally highly hydrophobic, which reduces their bioavailability and efficacy. 
Sibiya et al. showed that once off application of an-OA patch reduces parasit-
emia and TNF-α plasma levels [137]. Exposure of the host to malaria activates 
macrophages which in turn induces production of TNF-α and then the release 
of other cytokines such as IL-6 which initiate inflammation. Reports also indi-
cate the efficacy of another promising pentacyclic triterpene (maslinic acid) 
to alleviate malaria and inflammation in general. Extensive in vivo and in vitro 
studies indicate that MA reduces inflammation by reducing lipopolysaccharides 
(LPS)-induced production of nitric oxide (NO) and INOS gene expression [132] 
Márquez et al. also indicated that MA reduces the production of interleukin-6 
(IL-6) on peritoneal macrophages [132] (Figure 5).
7.4 Anti-inflammatory effects of Asiatic acid (AA) in malaria
Many parasitic and metabolic diseases are built upon inflammatory processes. 
Ample indications exist that phytopharmaceuticals may moderate innumerable 
inflammatory mediators, govern the production and action of second messengers, 
direct the expression of transcription factors and key pro-inflammatory mecha-
nisms [1, 2, 95, 115, 138–141]. The fundamental machinery of anti-inflammatory 
activity for AA in malarial may comprise: (i) anti-oxidative and radical scavenging; 
Figure 5. 
2D chemical structure of oleanolic acid (A) and maslinic acid (B) adapted from the PubMed database [134].
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(ii) inflammatory cellular components modulation (macrophages, lymphocytes 
neutrophils); (iii) modulation of expression and/or activity of pro-inflammatory 
enzymes such as phospholipase A2 (PLA2), cyclooxygenase (COX), lipooxygenase 
(LOX), iNOS and (iv) modulation of pro-inflammatory gene expression [138].
In malaria inflammation, the immune system-triggering-malaria-toxin is GPI 
which may be released pRBC rupture at erythrocytic schizogony [70]. GPI initiates 
TNF-α and lymphotoxin (formerly TNF-β) production [142], up-regulates ICAM-1 
and IVCAM-1 [5, 143].
Hemopoietic mediators of inflammation comprise Th1/M1 cytokines largely TNF-α, 
IL-1, IL-6, IL-18 and Th2/M2 cytokines IL-4 and IL-10. When produced excessively 
as in severe malaria, Th1 cytokines may lead to the generation of fever, hypoglycemia, 
bone marrow suppression, coagulopathies, hypergammaglobulinemia, hypotension and 
elevated acute phase reactants [55, 144]. The works by Clark and Chaudhri [144], show-
ing that TNF-α-induced dyserythropoiesis and erythrophagocytosis in malaria-infected 
animals, evidenced the association of SMA to inflammatory mediators and corroborated 
Peetre et al. who verified growth inhibition of culture hemopoietic cells [145].
Compounded, the anti-inflammatory outcome of AA may modify pro-
inflammatory apparatuses in malaria in the same way it does in other inflammatory 
diseases. Indeed, AA displays a dose-dependent (10 and 20 μsg/kg AA) selective 
induction of selective mitochondria-dependent apoptosis in activated Th1 cells. 
This averted concanavalin (Con-A)-induced murine fulminant hepatitis in a fashion 
that disrupted mitochondrial transmembrane potential, released cytochrome c, 
activated caspases and cleaved poly(ADP-ribose) polymerase [PARP] [146].
In malaria, hematological differential counts display exaggerated leukocytosis. 
As inflammatory response is similar regardless of cause, AA may modify Th1 over 
expression in malaria by eradicating activated cells. Moreover, in a mouse model for 
pain and inflammation, AA blocked the activation of NF-kβ [147], a major transcrip-
tion factor in the regulation of pro-inflammatory cells, cytokines and enzymes [148].
In unstimulated Th1 cells, NF-kβ subunit p65/p50, is sequestered in the cytoplasm 
bound to the inhibitory factor Ikβ-α. Proinflammatory signals in malaria comprising 
of GPI, cause the phosphorylation of Ikβ-α by Ikβ kinase (IKK) and its inactivation 
though the ubiquitin-mediated destruction. Liberated, NF-kβ translocate into the 
nucleus acting as pro-inflammatory mediator and transcription factor [70, 78, 148]. 
Eradication inflammatory responses is critical for overall health maintenance. AA 
may be able to inhibit GPI production or maintain inactivation of NF-kβ or both 
as this anti-inflammatory mechanism has been revealed in other diseases, and not 
malaria, when similar triterpenoid to AA, madecassoside (MA), was used [149–151].
By inhibiting activation of NF-kβ, AA may subsequently inhibit iNOS and 
COX-2 and reduce NO release. Moreover, AA (10 mg/kg) injected into Carrageenan-
induced paw edema inhibited expression of iNOS, COX-2 and NF-kβ in mice 
[147]. This may mean, in malaria, reduction in unrestrained vasodilation related 
to vascular permeability, pulmonary edema or renal dysfunction. Toxic oxidative 
activities causing tissue injury may likewise be ablated by a NO reduction and pos-
sibly superoxide [O2
•−] [151]. Certainly, AA has been predicted by a computational 
model AutoDock v.3.05 to bind iNOS. This binding inhibits iNOS’s strong affinity for 
arginine, exhibited as free energy binding (FEB) of −9.79 kcal.mol−1 [152–154].
Chemoattractant mediators hinging on NF-kβ activation may also be inhibited 
by AA resulting in abrogation of neutrophil-aggregation and inactivation of the 
linked oxidant and pro-inflammatory injury lytic enzymes [155]. Activation 
inhibition of peroxisome proliferator-activated gamma (PPAR-γ), which regulates 
inflammation through NF-kβ translocation, may be a route AA may confer anti-
inflammatory activity. A similar process has been confirmed with curcumin, a 
multi-faceted phytopharmaceutical [156]. The consequent action of this activation 
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will be up-regulation of CD36 in monocytes/macrophages for non-opsonic pRBC’s 
phagocytosis with parasite extrusion or destruction [157].
Credence of AA anti-inflammatory capacity in malarial pathophysiology has 
been shown. Indeed, the anti-inflammatory effect of AA has been reported in a 
murine malaria model where C-reactive protein was shown to be significantly 
reduced in infected transdermal AA administered animals as compared to infected 
chloroquine-treated animals and non-treated controls [95].
8. Conclusion
The strong connection between malaria pathophysiology and systemic inflam-
mation mobilizes various mediators, metabolic processes consummating in toxic 
cachexia, hypoglycemia, neuronal damage, coma and death. Numerous immuno-
logical and inflammatory response mediators drive the disease. Initial inflammatory 
response directed at alleviating and curtailing the infection through parasite killing 
turns around and aberrantly militates against the host. Hormonal involvement is 
crucial in maintain malaria tolerance by the host. The phytotherapeutics AA, Ma 
and OA intervention in malaria promises to engage the parasitic as well the inflam-
mation salvaging glucose homeostasis, neuronal death and other disease effects in 
malaria terminating the vicious cycle and alleviating the disease. Potential alterna-
tive treatment regimens for malaria are thus in the offing.
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of the Creative Commons Attribution License (http://creativecommons.org/licenses/
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